Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin - Reply

被引：15
|
作者：
Zeuzem, S [1 ]
机构：
[1] Saarland Univ Hosp, D-66421 Homburg, Germany
来源：
JOURNAL OF HEPATOLOGY | 2005年 / 42卷 / 02期
关键词：
D O I：
10.1016/j.jhep.2004.11.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：276 / 277
页数：2
相关论文
共 50 条
  • [21] Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C
    Satsangi, Sandeep
    Mehta, Manu
    Duseja, Ajay
    Taneja, Sunil
    Dhiman, Radha K.
    Chawla, Yogesh
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 859 - 863
  • [22] Hepatitis C and treatment with pegylated interferon and ribavirin
    Gotto, J
    Dusheiko, GM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (10): : 1874 - 1877
  • [23] Nitazoxanide plus pegylated interferon and ribavirin in the treatment of genotype 4 chronic hepatitis C, a randomized controlled trial
    Shehab, Hany M.
    Elbaz, Tamer M.
    Deraz, Dalia M.
    [J]. LIVER INTERNATIONAL, 2014, 34 (02) : 259 - 265
  • [24] Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
    Nattiya Kapol
    Surasit Lochid-amnuay
    Yot Teerawattananon
    [J]. BMC Gastroenterology, 16
  • [25] Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
    Kapol, Nattiya
    Lochid-amnuay, Surasit
    Teerawattananon, Yot
    [J]. BMC GASTROENTEROLOGY, 2016, 16
  • [26] Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin
    Fung, James
    Lai, Ching-Lung
    Hung, Ivan
    Young, John
    Cheng, Charles
    Wong, Danny
    Yuen, Man-Fung
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (06): : 808 - 812
  • [27] Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    Legrand-Abravanel, F
    Nicot, F
    Boulestin, A
    Sandres-Sauné, K
    Vinel, JP
    Alric, L
    Izopet, J
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2005, 77 (01) : 66 - 69
  • [28] Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus:: Prospective, non-randomized study
    Escudero, Amparo
    Rodriguez, Felicidad
    Serra, Miguel A.
    del Olmo, Juan A.
    Montes, Francisco
    Rodrigo, Jose M.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (06) : 861 - 866
  • [29] Combination therapy with pegylated interferon plus ribavirin in the treatment of hepatitis C virus-related thrombocytopenia
    Karakan, T
    Cindoruk, M
    Degertekin, B
    Dogan, I
    Sancak, A
    Dumlu, S
    Gorgul, A
    Unal, S
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2005, 66 (03): : 247 - 253
  • [30] Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
    Huang, Ching-I
    Huang, Chung-Feng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Yeh, Ming-Lun
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Wang, Liang-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (05) : 1012 - 1018
12345